Alnylam Pharmaceuticals Inc. (ALNY) said that new data from the HELIOS-B Phase 3 study of vutrisiran showed that the drug attenuated ...

Purpose: The treatment options for viral myocarditis caused by coxsackievirus B are summarized. Summary: Myocarditis is a common cause of dilated cardiomyopathy. The most common causes of ...

Capricor announced it intends to file a BLA for deramiocel for treatment of patients with DMD cardiomyopathy. Click here to ...

Patient randomization is underway in SONATA-HCM clinical trial evaluating Lexicon’s novel dual SGLT1 and SGLT2 inhibitor in this underserved and ...

It affects about 1 in 2,000 to 1 in 5,000 people, most of whom are between 20 and 40 years old.With ARVC, scar and fatty ...

Treatment often focuses on the use of anticoagulant ... Read More: What to Know About Hypertrophic Cardiomyopathy in Kids Ventricular tachycardia is another type of abnormal heart rhythm, in ...

4 Treatment is supportive and guided by hemodynamics and the presence of left ventricular outflow tract obstruction Treatment of hemodynamically stable patients follows standard guidelines for ...

Phoenix researcher was recently awarded a $1.9 million National Institutes of Health grant to study the molecular mechanisms of how dilated cardiomyopathy progresses to heart failure, which could ...

Discover BridgeBio Pharma's groundbreaking patent for treating ATTR cardiomyopathy with Compound 1, showcasing improved patient outcomes and reduced mortality rates.

With the recipient facing extreme breathing difficulty, a heart transplant was the only option left. While his family waited ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...

Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...